SCHEMBL17430693

SCHEMBL17430693

CC(C)=CCCCC(C)C1CCC2C3CCC4C(C)(C)C(C(OO)c5cc(N)cc(N)c5)CCC4(C)C3CCC12C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.42
OSBP P22059 4/20 0.38
OSBP2 Q969R2 3/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPC1L1 Q9UHC9 2/20 0.38
INPP5D Q92835 1/20 0.37
ST6GAL1 P15907 2/20 0.37
PTPN1 P18031 1/20 0.37
GRIN1 Q05586 3/20 0.37
GRIN2A Q12879 3/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
ABCB1 P08183 1/20 0.37
CYP46A1 Q9Y6A2 1/20 0.37
CD4 P01730 1/20 0.36
CCR1 P32246 1/20 0.36
NR1H3 Q13133 2/20 0.36
GRIN2B Q13224 2/20 0.36
FNTA P49354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10054759 0.95 RORC (0.47) RORCOSBPOSBP2CYP2C19PTPN1
SCHEMBL10054753 0.89 CYP2D6 (0.48) RORCOSBPOSBP2CYP2D6CYP2C19
SCHEMBL11994878 0.89 HMGCR (0.35) RORCPTPN1USP2LMNA
SCHEMBL10017548 0.88 CYP2D6 (0.41) RORCOSBPOSBP2CYP2D6CYP2C19
SCHEMBL14902980 0.88 RORC (0.41) RORCOSBPOSBP2CYP2D6CYP2C19
SCHEMBL12248254 0.86 RORC (0.45) RORCOSBPOSBP2CYP2D6CYP2C19
SCHEMBL14552059 0.83 RORC (0.51) RORCOSBPOSBP2NPC1L1PTPN1
SCHEMBL12172527 0.81 RORC (0.41) RORCPTPN1USP2LMNACD4
SCHEMBL12577480 0.80 RORC (0.51) RORCOSBPOSBP2ST6GAL1PTPN1
SCHEMBL15803798 0.79 RORC (0.61) RORCOSBPOSBP2NPC1L1GRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160011463-A1 LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160011463-A1 LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME PYM1, PDCD2L, SDAD1 RORC 4339/4885OSBP 2382/4885OSBP2 1522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.